论文部分内容阅读
前言随着人类社会生活水平的提高,心血管系统的发病率也随之相对升高。心血管疾病已成为常见病、多发病,严重危害人们的生命和健康,是许多国家人口死亡的首位原因。据美国1989年统计,死亡原因最多的是心脏病为776,000人,而高血压列为第三位为138,000人。美国心血管药物使用量约占世界心血管药物的一半。我国高血压也为常见病,由高血压引发心脑血管病致死率在国内居首位。心血管药物能减少心血管病的发病率和患病率,对提高人类的健康水平,延长人类的寿命,具有重大的社会效益;搞好心血管药物的
Preface With the improvement of human living standards, the incidence of cardiovascular system will also be relatively increased. Cardiovascular disease has become a common disease, frequently-occurring disease, seriously endangering people’s lives and health, is the number one cause of death in many countries. According to the statistics of the United States in 1989, the most frequent cause of death was heart disease of 776,000 and hypertension as the third highest of 138,000. The use of cardiovascular drugs in the United States accounts for about half of the world’s cardiovascular drugs. Hypertension is also a common disease in our country, caused by hypertension-induced cardiovascular and cerebrovascular mortality in the country top. Cardiovascular drugs can reduce the incidence and prevalence of cardiovascular disease, to improve human health and extend human life expectancy, with significant social benefits; do a good job of cardiovascular drugs